Company / Current Assets
Eton Pharmaceuticals, Inc. Current Assets History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$60.6M
FY2025
5-year range
$20.0M / $60.6M
FY2021-FY2025
Trend
+47.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has increased for 3 consecutive years, from $20M in FY2022 to $61M in FY2025.
Based on SEC 10-K filings.
$61M in FY2025 with a 5-year CAGR of +19.7%.
Improved from $27M to $61M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- +44.7%
- 5-Year CAGR
- +19.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- Eton Pharmaceuticals, Inc.'s current assets has grown for 3 consecutive years.
- 5-year CAGR of +19.7%, indicating consistent growth.
- In FY2025, current assets increased 47.7% year-over-year.
- Lowest current assets in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.63 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $60.6M | +47.7% |
| FY2024 | $41.0M | +52.8% |
| FY2023 | $26.8M | +34.2% |
| FY2022 | $20.0M | -15.3% |
| FY2021 | $23.6M | -4.4% |
| FY2020 | $24.7M | +64.6% |
| FY2019 | $15.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026